Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

QT Vascular

QT Vascular
2005 FOUNDED
PUBLIC STATUS
5I0 STOCK SYMBOL
2 INVESTMENTS
Description

QT Vascular Ltd engages in the development and distribution of therapeutic solutions for the treatment of vascular diseases. It designs, assembles, and distributes therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The firm offers coronary products, including Chocolate percutaneous transluminal coronary angioplasty (PTCA) balloon catheter to reduce vessel trauma; and Glider PTCA for the treatment of various complex lesions. It also offers Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter for the treatment of blocked arteries; Chocolate Touch, a drug-coated balloon catheter; GliderfleX PTA for treating distal peripheral vessels; and GliderXtreme PTA balloon catheter that targets complex lesions in the distal peripheral vasculature.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Therapeutic Devices
Stock Exchange
SES
Primary Office
  • 3A International Business Park
  • No. 09-10/11/12 ICON IBP Tower B
  • Singapore, 609935
  • Singapore
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore QT Vascular’s full profile, request a free trial.

QT Vascular Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$4.97M -$0.01 4.11M 2.24B

QT Vascular Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 3,684 (2,148) 27,343 66,822
Revenue 9,661 11,165 14,312 10,645
EBITDA (10,385) 30,014 (15,960) (255)
Net Income (10,260) 29,572 (22,871) (11,978)
Total Assets 15,593 24,262 17,659 19,892
Total Debt 1,773 2,389 10,008 17,822
Public Fundamental Data provided by Morningstar, Inc. disclaimer

QT Vascular Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore QT Vascular‘s full profile, request access.

Request full access to PitchBook

QT Vascular Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cagent Vascular Venture Capital-Backed Wayne, PA 0 000.00 00000000000 000.00
0000000 Private Equity-Backed Burnaby, Canada 00 00.000 0000000 0000 00.000
00000000000 Venture Capital-Backed Marlborough, MA 00 00000 0000000000 0 00000
0000000 0000000000 Venture Capital-Backed Kirkland, WA 00 00000 00000000000 00000
0000000 Formerly VC-backed Redwood City, CA 00 00000 00000000 00000
To view this company’s complete list of competitors, request access »

QT Vascular Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0 19-Dec-2018 00000 00000 00 00000 Other Healthcare 00000 00000000000 00.0
TriReme Medical 11-Jul-2013 Merger of Equals Surgical Devices
To view this company’s complete investment and acquisition history, request access »

QT Vascular Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore QT Vascular‘s full profile, request access.

Request full access to PitchBook

QT Vascular Executive Team (3)

Name Title Board
Seat
Contact
Info
Eitan Konstantino Ph.D Co-Founder, Chief Executive Officer & Board Member
Randal Farwell Chief Financial Officer
Maria Pizarro Executive Vice President and Vice President of Research & Development

QT Vascular Board Members (8)

Name Representing Role Since Contact
Info
Amir Belson MD Self Board Member 000 0000
Eitan Konstantino Ph.D QT Vascular Co-Founder, Chief Executive Officer & Board Member 000 0000
Gary Ng QT Vascular Board Member 000 0000
Gregory Casciaro Self Board Member 000 0000
Mark Wan Three Arch Partners Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 8 board members. Get the full list »